DILIC
ABMD

Dai-ichi Life Insurance Company’s Abiomed Inc ABMD Stock Holding History

Dai-ichi Life Insurance Company’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-11,045
Closed -$2.88M – 540
2019
Q2 		$2.88M Buy
11,045
+26
+0.2% +$6.9K 0.07% 267
2019
Q1 		$3.15M Buy
11,019
+5,000
+83% +$1.66M 0.08% 252
2018
Q4 		$1.96M Hold
6,019
– – 0.05% 306
2018
Q3 		$2.71M Hold
6,019
– – 0.06% 286
2018
Q2 		$2.46M Buy
+6,019
New +$2.18M 0.06% 294

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Dai-ichi Life Insurance Company's ABMD Position: Q3 2019 in Review

Dai-ichi Life Insurance Company sold out of Abiomed Inc (ABMD) in Q3 2019, closing a stake of 11,045 shares — an estimated $2.88M sold.

Dai-ichi Life Insurance Company first reported a position in ABMD in Q2 2018 and held it in 5 quarters. The position peaked at $3.15M in Q1 2019. 443 funds tracked by Wall St. Rank hold ABMD as of Q3 2019.

  • Dai-ichi Life Insurance Company reported no remaining Abiomed Inc position as of Q3 2019 after selling out during the quarter.
  • Dai-ichi Life Insurance Company sold 11,045 Abiomed Inc shares in Q3 2019, an estimated $2.88M.
  • Dai-ichi Life Insurance Company first reported a position in Abiomed Inc in Q2 2018 and held it in 5 quarters.
  • Dai-ichi Life Insurance Company's Abiomed Inc position peaked at $3.15M in Q1 2019.
  • 443 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2019.

Based on Dai-ichi Life Insurance Company's 13F filing for Q3 2019, filed 13 Nov 2019.